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We determined T-cell cytokine profiles in the epidermis, 
dermis, and blood of cutaneous T-cell lymphoma to differ-
entiate whether unique cytokine profiles were associated 
with mycosis fungoides (MF) versus Sezary syndrome. Punch 
biopsy specimens from plaque stage MF (n = 7) were com-
pared to Sezary skin (n = 3) after undergoing rapid heat-sa-
line separation of epidermis from dermis . Normal adult skin 
(n = 11), neonatal foreskin (n = 4), untreated psoriatic 
plaques (n = 6), and normal donor peripheral blood leuko-
cytes (n = 3) were studied as controls. Total RNA was ex-
tracted from all skin specimens, as well as peripheral blood 
leukocytes from MF (n = 3) and Sezary patients (n = 7), and 
was converted to cDNA by reverse transcriptase. Polymerase 
chain reaction amplification of cDNAs using interleukin 2 
(IL-2), IL-4, IL-S, IL-lO, and interferon y-specific primers 
was used to differentiate Thl-type responses (IL-2+ and in-
terferon y+) from Th2-type responses (IL-4+, IL-S+, and 
IL-l0+). p-actin specific primers were included as a positive 
M urine T-helper cells have been divided into two distinct functional subsets (Thl and Th2) [1]. The difference between these two types of cloned T-helper cells is primarily defined by the profiles of cytokines synthesized. Th 1 clones synthesize in-
terleukin 2 (IL-2), interferon y (IFNy), and lymphotoxin, which 
results in augmented cell- mediated immunity , T-cell proliferation, 
and macrophage activation. These cytokines are not expressed in 
Th2 clones, which preferentially synthesize IL-4, IL-S, and IL-10 
and augment humoral responses, while suppressing cell-mediated 
immunity [2]. Patterns of cytokine mRNA expression can be used to 
separate T-cell subclass differences, and increasing evidence sup-
ports that many of the functions of T-helper cells are predicted by 
the cytokines they synthesize. Separation of human T-helper cell 
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control for mRNA integrity. All MF specimens contained 
mRNAs for IL-2 and interferon y limited to epidermis but no 
IL-4, IL-S, or IL-10. In contrast, Sezary skin and blood 
showed a cytokine mRNA pattern dominated by IL-4, IL-S, 
and IL-10. MF blood showed a pattern similar to normal 
peripheral blood T cells with mixed detection of all T -helper 
cell cytokine mRNAs. All psoriasis samples contained 
mRNAs for IL-2 and interferon y in both epidermis and 
dermis with no IL-4 or IL-10 in either compartment. These 
findings demonstrate that the cutaneous lesions of MF are 
characterized by an epidermal Thl-type cytokine profile, 
whereas both the blood and skin of patients with Sezary 
syndrome is characterized by a Th2-type profile. This work 
suggests that differences in cytokine production may be re-
lated to the pathophysiology and clinical presentation in cu-
taneous T-cell lymphoma. Key words: cutaluous T-cell lym-
phoma/cytokines/psoriasis/interleukins/gamma inte1eron/PCR. 
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clones into analogous subsets is now established [3], and human skin 
diseases can be differentiated based on their characteristic cytokine 
profiles [2,3]. 
Lesions of tuberculoid leprosy and psoriasis are characterized by a 
Th 1 cytokine profile and these diseases are characterized by intact 
cell mediated immunity. Conversely, lepromatous leprosy and 
atopic dermatitis bear a Th2 profile and are characterized by altered 
cell mediated immunity [2-4] . We have used the reverse transcrip-
tase-polymerase chain reaction (RT-PCR) technique to determine 
the cytokine mRNA expression profiles in cutaneous T-celllym-
phoma (CTCL) in comparison to psoriasis and normal skin. In 
CTCL we wanted to determine if distinctive cytokine profiles were 
present in mycosis fungoides (MF) versus Sezary syndrome and, if 
so, how would they compare with the recently characterized pat-
terns in infectious skin disease (i.e. , Hansen's disease) and reactive 
cutaneous diseases (i.e .• psoriasis and atopic dermatitis). Differences 
in cytokine response profiles may be related to prognosis, as patients 
with CTCL are known to lose cell mediated immunity as their 
disease progresses. Not unlike Hansen's disease, CTCL is clinically 
characterized by limited cutaneous disease that is well tolerated and 
features intact cell- mediated immunity, whereas disseminated 
forms of the disease (e.g. , extensive tumor stage MF and Sezary 
syndrome) are frequently fatal and lack adequate cell mediated im-
munity. We extend the previous report ofThl cytokine pattern in 
psoriasis [3] and report that MF patients are characterized by a dis-
tinct epidermal Thl-rype phenotype, whereas Sezary syndrome 
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patients express a Th2-type cytokine profile in both blood and skin 
compartments. 
MATERIALS AND METHODS 
Patient Specimens Skin punch biopsy samples (4 to 6 mm) were ob-
tained from adult patients with histologically confirmed plaque-stage MF 
(11 = 7), and erythematous skin of patients with untreated Sezary syndrome 
(n = 3). All skin biopsies from CTCL patients were of classic histopathology 
with a moderately dense infiltrate of hyperchromatic lymphocytes in the 
dermis of MF and Sezary skin samples. MF samples all contained prominent 
epidermotropism, whereas Sezary skin samples contained few epidermal 
lymphocytes. Ethylenediaminetetraacetic acid - anticoagulated blood sam-
ples (10-20 ml) were obtained from patients with Sezary syndrome (n = 7) 
and patients with plaque-stage MF (n = 3). Sezary blood specimens were 
collected prior to treatments from patients at Henry Ford Hospital and the 
Universiry of Cincinnati Medical Center. All patients had circulating "Se-
zary cells" on their peripheral smear and Sezary counts ranged from 7 to 
480/0. These patients were compared with untreated psoriasis (n = 6), neo-
natal foreskin (n = 4), normal, non - sun-exposed skin obtained from 
healthy volunteers (n = 11), and normal donor blood samples (n = 3). All 
procedures were under approval of the Henry Ford Hospital and the Univer-
sity of Michigan Medical Center, Institutional Review Boards. 
Heat-Split Skin Skin biopsies were immersed in 0.15 M NaCl, pre-
heated to 60·C, for 5-7 min in a water bath, and then transferred to 0.15 M 
NaCI on ice. Epidermis was then peeled off dermis with sterile forceps and 
separated epidermal sheets and dermal fragments were placed in guanidi-
nium isothiocyanate buffer (5.5 M guanidinium isothiocyanate containing 
25 mM sodium citrate, pH 7.0, with 0.50/0 sarcosine and 0.1 M 2-metcap-
toethanol) for RNA extraction. This technique has been previously reported 
to cause a separation in the lamina lucida and routinely provides viable RNA 
for PCR studies [5]. 
RNA Extraction Total RNA was isolated from skin biopsies and buffy 
coat preparations of peripheral blood by the cesium trifluoroacetate method. 
as previously described (6). Briefly, tissues were homogenized in 2-3 mlof 
guanadinium isothiocyanate buffer with a Polytron (Brinkmann Instru-
ments, Inc., Westbury, NY). The homogenate was centrifuged at 1500 X g 
for 5'min to peller insoluble material, after which DNA was sheared by 
passing the lysate through a 16-18 gauge needle. The lysate was overlaid 
onto a cesium trifluoroacetate gradient cushion (Pharmacia-LKB Biotech-
nology, Piscataway, NJ) and centrifuged at 100,000 Xg in a swinging-
bucket rotor for 24 h at 15 · C. RNA formed a pellet on the tube bottom and 
was dissolved in RNase-free water. The RNA concentration was then deter-
mined by measurement of optical density at 260 nm. 
eDNA Synthesis eDNA was synthesized from total RNA using 200 units 
of Molony murine leukemia virus reverse transcriptase (Bethesda Research 
Laboratories, Bethesda, MD) in a 20-JlI reaction containing enzyme buf-
fer together with various RNA samples, 20 units of RNasin, 0.5 Jlg oligo 
(dT)12.18 primer, and 1 mM from (each) deoxynucleoside triphosphate. The 
reaction mixture was incubated at 37"C for 60 min, heated at 95·C for 
5 min, and then chilled on ice to inactivate the enzyme (6]. 
PCR Amplification Two- to five-microliter aliquots from the cDNA 
reaction products were PCR amplified in 100 JlI reaction as follows: 10 JlI of 
10 X PCR reaction buffer, 1 mM from each ohhe deoxynucleoside triphos-
phates, 20 J-lM from each primer, and 2.5 units of Tag polymerase enzyme 
(Perkin-Elmer Cetus, Norwalk, CT) and overlaid with mineral oil to pre-
vent evaporation. The reaction was initiated by heat denaturation at 95·C 
for 1 min, annealing/extension for 2 min at 55·C (IFNy, IL-2, and IL-5) or 
60·C (lL-4, IL-I0,,B-actin). This was repeated for 35 cycles using the PCR 
(Perkin-Elmer Cetus). After the final cycle, the temperature was maintained 
at 72 · C for 7 min to allow completion of synthesis of amplified products 
[6,7). PCR products were visualized with 2% agarose gel electrophoresis 
stained with ethidium bromide. All results were confirmed by Southern 
blotting of these gels. The gel was transferred onto nylon membranes by 
capillary blotting, and then hybridized with 32p end-labeled "nested" probes 
designed to recognize intervening sequences between each respective set of 
primers ([2,6], see below) . 
PCR Primers Cytokine-specific primers used for all specimens in this 
study were identical to those reported elsewhere [3). These primers were 
chosen to span introns that helped ensure amplification of only cDNA and 
not genomic DNA. Nucleotide sequences for the upstream and downstream 
primers used were as follows: 
lL-2: 5' -ACTCACCAGGATGCTCACAT -3' and 
5' -AGGT AA TCCA TCTGTTCAGA-3' 
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ILA: 5' -CTTCCCCCTCTGTTCTTCCT -3' and 
5'-TTCCTGTCGAGCCGTTTCCAG-3' 
IL-S: 5'-ATGAGGATGCTTCTGCATTTG-3' and 
5'-TCAACTTTCTATTATCCACTCGGTGTTCATTAC-3' 
IL-IO: 5'-ATGCCCCAAGCTGAGAACCAAGACCCA-3' and 
5' -TCTCAAGGGGCTGGGTCAGCT ATCCCA-3' 
IFNy: 5'-AGTTATATCTTGGCTTTTCA-3' and 
5' -ACCGAA T AA TT AGTCAGCTT -3' 
ft-actin: 5'-GTGGGGCGCCCCAGGCACCA-3' and 
5' -CTCCTT AA TGTCACGCACGA TTTC-3'. 
Nested Probes for Southern Blot of PCR Products 
IL-2 probe: 5'-AGCTAAATTTAGCACTTCCTCCAG-3' 
IL-4 probe: 5'-CTCGGTGCTCAGAGTCTTCTGCTCT-3' 
IL-S probe: 5'-GCCAATGAGACTCTGAGGATTCCTG-3' 
IFNy probe: 5' -A TTTGGCTCTGCA TTTTTCTGT-3' 
IL-tO probe: 5'-CAGGTGAAGAATGCCTTTAATAAGCTCCAA-
GAGAAAGGCATCTACAAAGCCATGAGTGACTTTGA-
CATC-3' 
Controls and Standardization cDNA amplification products were dis-
tinguished from genomic DNA by size on agarose gel electrophoresis. 
,B-actin, which is constitutively expressed by all cell types, was used to ensure 
that viable total cellular mRNA was recovered from each specimen. As a 
negative control the RT/PCR reaction was performed exactly as described 
above omitting reverse transcriptase from the reaction mixture from each 
specimen to distinguish between amplification of contaminating genomic 
DNA from mRNA in each sample. 
RESULTS 
The results of the cytokine mRNA analyses of MF and Sezary skin 
lesions, and peripheral blood T cells in these CTCL patients, as 
compared to normal skin, neonatal foreskin, lesional psoriatic skin, 
and normal T cells are summarized in Table 1. cDNA specimens 
from epidermis, dermis, and buffy coat cells were separately PCR 
amplified with IL-2, IL-4, IL-5, IL-lO, and IFNy primers. PCR 
products were analyzed by 2% agarose gel electrophoresis, stained 
with ethidium bromide, and confirmed by Southern blot using 32p 
end-labeled nested probes. All samples used in these experiments 
gave an identical amplified band with the p-actin primers indicating 
integrity of RNA. Individual patient results were qualitatively eval-
uated in comparison to their p-actin signal to allow comparisons 
between samples (Fig 1). 
All MF specimens contained mRNA transcripts for IL-2 and 
IFNy limited to epidermis, with no detectable IL-4, IL-5, or IL-I0 
in either skin compartment (Fig 2). The skin from Sezary patients 
showed a Th2-type cytokine profile with mainly IL-4, IL-S, and 
IL-IO mRNAs present in three of three epidermal skin specimens 
(no detectable T-helper cell cytokines were found in Sezary dermis 
as in MF dermis). One of three Sezary skin samples revealed detect-
able IFNy mRNA in the epidermis by Southern blot analysis (all 
three were negative on ethidium bromide gels, results not shown). 
All !;even Sezary blood T cells contained readily detectable mRNAs 
for lL-4 and IL-10 but no IL-2 or IFNy mRNAs (Fig 2). IL-S was 
detected in two of five specimens of Sezary blood T cells studied. 
The absence ofIL-4, IL-5, and IL-10 mRNAs in MF skin as well as 
the absence of IL-2 and IFNy mRNAs in Sezary blood and skin 
samples was confirmed by Southern blot. Peripheral blood T cells 
frortl MF patients gave a mixed pattern of T-helper cell cytokine 
expression with mRNAs. 
All normal adult skin specimens contained detectable mRNA for 
IL-IO in the epidermis. Four of 11 also had IFNy in both epidermis 
and dermis, but no IL-2, IL-4, or IL-5 in either compartment (Fig 
3A) by ethidium bromide staining. The variability ofIFNy expres-
sion in normal adult skin was confirmed by Southern blot of PCR 
products from separated epidermis versus dermis. Of the specimens 
with negative results for IFNy mRNA in normal adult skin Oil 
ethidium bromide stained gels, five of seven epidermal specimens 
had detectable IFNy by Southern blot (Fig 3B). 
All psoriasis specimens contained mRNAs for IL-2 and IFNy in 
both epidermis and dermis but no IL-4 or IL-IO in either compart-
ment (Fig 4), confirming a previous report using intact skin samples 
(5}. Neonatal foreskin epidermis and dermis contained mRNAs for 
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Table I. Cytokine mRNA Profiles in Skin and Blood of Cutaneous T-Cell Lymphoma Patients as Compared to Psoriasis and Controls 
Cytokine 
mRNA 
MF' (n = 7) MF (n = 3) SZ (n = 3) SZ (n = 7) NS (n = 11) FK (n = 4) PS (n = 6) 
IL-2 
IL-4 
IL-5' 
IL-l0 
IFNy 
p-actin 
Eb 
+ 
+ 
+ 
0 B 
± 
± 
± 
± 
± 
+ + 
E 
+ 
+ 
+ 
± 
+ 
D 
± 
+ 
B 
+ 
± 
+ 
+ 
E 
+ 
± 
+ 
o 
± 
+ 
E 
+ 
ND 
+ 
+ 
+ 
D E 0 
+ + + 
+ 
ND 
+ 
+ + + 
+ + + 
• NS, normal skin; FK, foreskin; PS, psoriasis; MF, mycosis fungoides lesional skin; SZ, Sezary syndrome. 
I E, epidermis; D, dermis; B, peripheral blood T cells; +, mRNA detected in all samples; - , mRNA not detected in any sample; ±, mRNA detected in some bur not all samples (all 
results confirmed by Southern analysis using 32P-labeled nested probes. 
, IL-S was studied in seven MF epidermis and dennis samples, four MF blood samples, three SZ epidermis and dermis samples, five SZ blood samples, and five nonnal adult 
epidermis and dermis samples only. ND, not done. 
IL-lO and IFNy (four of four samples), IL-2 (three of four epider-
mis, two of four dermis), and IL-4 (three of four dermis only), 
suggesting a mixed cytokine pattern, consistent with nonspecific 
inflammation (see Table I). IL-s was not studied in psoriasis or 
foreskin samples. Normal donor leukocytes were found to express 
detectable mRNAs for IL-2, IL-4, IL-lO, and IFNy in all samples 
and IL-s in three of eight samples (results not shown). 
DISCUSSION 
We report that cutaneous lesions of MF are characterized by a dis-
tinct epidermal Th l - type cytokine phenotype, whereas the leuke-
mic variant of CTCL, Sezary syndrome, expresses a Th2-type phe-
notype in both blood and skin. This study highlights that both 
malignant and reactive T -cell- mediated skin diseases are character-
ized by unique cytokine mRNA profiles as data is also presented that 
confirms that psoriasis also expresses a Th1-type profile [2]. These 
results qualitatively demonstrate that cutaneous lesions of plaque-
stage MF are shown to be characterized by IL-2 and IFNy mRNAs, 
and the predominant source of these cytokines appears to be epider-
mal. Sezary syndrome is also reported to have cutaneous cytokine 
transcription restricted to the epidermis with only IL-4, IL-s, and 
IL-10 regularly detected . The dermis of all CTCL specimens stud-
ied was devoid of these cytokine mRNAs despite consistent yields of 
RNA as evidenced by positive dermal p-actin signals (see Fig 1) 
indicative of ongoing transcriptional activity. The restriction of 
specific cytokine-response profiles to the epidermis in CTCL is 
consistent with our recent observations that proliferative (Ki-67+, 
proliferating cell nuclear antigen [PCNA]+), clonal T-cell popula-
tions in MF are also restricted to the epidermis [8 -10]. Thus it 
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Figure 1. RT-PCR analysis of P actin from representative specimens of 
each tissue studied. PCR analysis of total RNA isolated from the epidermis 
(E) and dermis (D) from one representative skin biopsy each of mycosis 
fungoides (MF), psoriasis (PS), neonatal foreskin (FK), and normal skin 
(NS). RNA samples were PCR amplified using primers specific for p-actin. 
PCR products were electrophoretically separated on 2% agarose gel and 
visualized by ethidium bromide staining. 
appears that the epidermis of MF and Sezary syndrome are both 
characterized by clonal, proliferative T cells yet are associated with 
completely different cytokine profiles . 
The blood of MF patients showed no unique cytokine pattern as 
compared to normal blood, in agreement with the lack of detection 
of malignant clones by Southern blot in the blood of most MF 
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Figure 2. RT-PCR analysis ofT-helper cytokine InRNAs in mycosis fun-
goides and Sezary syndrome. A) peR analysis of total RNA isolated from 
the epidermis (E) and dermis (D) of a skin biopsy from a patient with 
untreated patch-stage mycosis fungoides (M). B) peR analysis of total RNA 
isolated from peripheral blood leukocytes from a patient with Sezary syn-
drome (SZ). In both experiments, RNA samples were PCR amplified using 
primers specific to IL-2, IL-4, IL- 1 0, and IFN)'. peR products were electro-
phoretically separated on 2% agarose gel and visualized by ethidium bro-
mide staining. The DNA size marker (M) was the BioMarker Low (BioVen-
tures Inc.). 
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Figure J. RT-PCR analysis ofT-helper cytokjne mRNAs in normal skin. 
A) PCR analysis of cytokines mRNA isolated from the epidermis (E) and 
dermis (D) of a representative normal adult skin biopsy from the buttocks. 
RNA samples were PCR amplified using primers specific to IL-2, IL-4, and 
IL-IO. PCR products were electrophoretically separated on 2% agarose gel 
and visualized by ethidium bromide staining. B) PCR analysis of cytokines 
mRNA isolated from the epidermis (E) and dermis (D) from two specimens 
of normal skin. RNA samples were PCR amplified using primers specific for 
IFN y. PCR products were electrophoretically separated on 2% agarose gel 
and then Southern blotted using a 32P-labeled IFNy-specific oligonucleotide 
probe as no bands could be detected by ethidium bromide staining. 
patients [11]. Similar to the recent study by Vowels et af [12], we 
report that Sezary blood T cells are characterized by a Th2-type 
cytokine profile and extend this observation to include Sezary skin 
lesio ns. Our results complement the Vowels et af study, in which 
they report the production of a Th2 cytokine profile based on bioas-
say of cultured Sezary leukocytes. We confirm that the cytokines 
expressed at the mRNA level by Sezary syndrome T cells are IL-4, 
II -S, and IL-10, matching the murine Th2 profile [1]. Earlier work 
from our laboratories predicted that Sezary syndrome was likely to 
be characterized by defective IFNy expression as Sezary epidermis 
was found to be lacking intercellular adhesion molecule-1 (I CAM-
1) expression, which is transcriptionally regulated by IFNy [13]. 
These findings also support those of Par ron chi et af [14] in that there 
appears to be an inhibition of IFNy by IL-4, as no detectable IFNy 
mRNA was found in the blood ofSezary patients, despite the highly 
sensitive Southern analysis of all PCR products. 
In normal adult skin, no detectable IL-2, IL-4, or IL-5 mRNA 
was present in the epidermis or dermis. The majority of epidermal 
specimens could be shown to have detectable IFNy expression, sug-
gesting that the epidermis of normal skin bears some cell(s) that 
constitutively make low levels of IFNy mRNA. This trace IFNy 
expression may be due to the occasional migration of Th 1 cells in 
the epidermis of normal adult skin or may result from other resident 
epidermal cell populations such as Langerhans cells [15]. Dermal 
IFNy was regularly observed in normal adult skin and could be 
attributable to resident T cells in the perivascular space as described 
by Bos et af [16]. Epidermal expression of1L-10 is also reported in 
this study as a regular finding in normal adult skin and may function 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
to suppress pro-inflammatory cytokine release from resident T cells 
in the epidermis and dennis. Th us epidermal IL-10 may counter-
balance any significant effects of epidermal IFNy production. Basal 
expression of IL-10 mRNA has also been recently shown in unsti-
mulated murine keratinocyte cultures [17]. Thus low levels of cyto-
kine expression may be responsible for maintenance of adhesion 
molecule mediated epidermal and dermal immune cell trafficking 
and surveillance in normal skin as well as in CTCL and psoriasis. 
Our data also confirm that psoriasis is characterized by a Th 1-
type cytokine profile, as recently suggested by Uyemura et al [3] . 
Separate epidermal and dermal analysis of psoriasis specimens re-
vealed that, in contrast to CTCL, T-cell cytokines are transcribed in 
both epidermis and dermis. Thus only specimens of malignant T-
cell mediated skin disease (e.g., CTCL) have been shown to demon-
strate epidermal selectivity forTh cytokine transcription. The path-
ogenesis of this phenomenon is unknown but may be due to factors 
including the unique location ofT cells within the epidermis and its 
rich milieu of keratinocyte-derived cytokines, the process of epider-
motropism, and/or compartment-specific reciprocal inhibition of 
cytokine mRNA transcription [14,18,19] . 
The differential cytokine response profile in MF (Th 1) and Se-
zary syndrome (Th2) suggests several possible explanations. The 
first of these is that all malignant T cells in CTCL are of Th2 type 
and that changes in profiles observed may be due to a predominantly 
reactive (e.g., benign) phenotype in the skin (Th 1) versus the blood 
(Th2) as suggested recently in an editorial by Rook et al [20]. The 
predominant Th 1-type response in the epidermis of MF may then 
overwhelm the relatively fewer malignant Th2-type cells to yield 
an effective anti-tumor response, allowing MF to remain indolent. 
The lack of detectable Th2-type cytokine mRNAs in the epidermis 
could be explained by transcriptional feedback inhibition by IL-2 
and IFNy [14], as the use ofRT-PCR with Southern analysis could 
have theoretically detected 1 cell/specimen expressing Th2 cyto-
kine mRNAs. Similar pathways resulting in the extracutaneous in-
hibition of Thl-type cytokines by IL-4, IL-S, and IL-10 could also 
explain the cytokine profile in the blood of Sezary syndrome pa-
tients, as the malignant Th2 clone dominates the circulatory com-
partment. The effect here would be for the Th2 cytokines to inhibit 
appropriate cell-mediated immune responses to the tumor cells (as 
observed in Sezary syndrome) and favor a more rapidly progressive, 
fatal disease process. Although this is still highly speculative, it 
could explain why MF patients treated with cyclosporin have been 
reported to have rapid worsening of their disease [21]. as this im-
mllne modulator inhibits IL-2 function, thus favoring Th2 cyto-
kines and suppression of cell-mediated immunity . Although data 
are not presented in this report, this model would predict that those 
patients who have increasing tumor cell density (i.e., tumor-stage 
MF) or who progress from MF to Sezary syndrome would be ex-
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Figure 4. RT -PCR analysis of T -helper cytokine mRNAs in psoriasis. 
PCR analysis of cytokilles mRNA isolated from the epidermis (E) and 
dermis (0) of an untreated psoriatic plaque. RNA samples were PCR ampli-
fied using primers specific to IL-2, IL-4, IL-IO, and IFNy. PCR products 
were electrophoretically separated on 2% agarose gel and visualized by 
ethidium bromide staining. 
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pected to go through a transition stage from Th 1 to Th2 that would 
parallel progression of their disease . IfTh cytokines do not fluctuate 
in the numbers of copies transcribed per cell, then this transition 
stage would be characterized by relatively comparable levels ofTh 1 
and Th2 cytokines, negating any transcriptional inhibition. How-
ever, if the rate of cytokine mRNA production changes with disease 
progression (either due to increased transcription or decreased 
mRNA turnover), then a minority of very active Th2 cells could 
produce sufficient quantities of IL-4, IL-S, and IL-10 to shut off 
IL-2 and IFNy production. This may explain why some of the 
Sezary patients studied with as few as 7% circulating malignant cells 
showed a "pure" Th2 mRNA phenotype in their blood. 
A second possibility is that compartment specific (epidermis 
versUS dermis versus blood) cytokine class switches occur in CTCL 
patients . In this model, malignant T cells in the epidermis of MF 
would be predicted to begin as Th 1 cells. Only after migration out 
of the skin would they switch to Th2 cytokines in the circulatory 
compartment as Sezary syndrome T cells. These malignant Th2 
cells would then be required to re-infiltrate the skin, to yield a Th2 
phenotype for the Sezary epidermis. Although no CTCL data is 
available to support this model, clonal murine T cells have been 
reported to produce either class of cytokines depending on environ-
mental (i.e., thymic) stimuli [22]. A third explanation for MF ex-
pression of a Th ~ ~y.tokine profile and ~ezary expression of a Th2 
profile is the pOSSlblhty that these two diseases are completely unre-
lated and that their Th cytokine productions are therefore unre-
lated. Although the weight of accumulated immunopathologic data 
would argue that these diseases are closely related, their disparate 
clinical courses does support such a hypothesis [12,20,23]. 
In summary, we report that CTCL demonstrates clear-cut differ-
ences in T-helper cell cytokine mRNA profiles between the skin 
and blood of patients with MF versus Sezary syndrome. An epider-
mal Th 1 phenotype is seen in the skin of MF lesions, analogous to 
that seen in psoriasis [2], whereas a Th2 phenotype is seen in Sezary 
syndrome in the epidermis and blood. Interrelation between types 
of CTCL seems to involve the differential expression of these cyto-
kines. Distinctive T-helper cell cytokine profiles associated with 
the epidermis versus dermis versus peripheral blood of patients with 
CTCL and psoriasis may be related to the pathophysiology of these 
T -cell- mediated disorders. 
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